Sellas Life Sciences (NASDAQ: SLS) is a biopharmaceutical company dedicated to developing novel cancer immunotherapies to improve the lives of patients with cancer. With a focus on innovative treatments that harness the power of the immune system, Sellas is at the forefront of advancing precision medicine in oncology. Through cutting-edge research and strategic partnerships, Sellas is committed to delivering groundbreaking therapies that have the potential to transform the treatment landscape for cancer patients worldwide.

Refer new talent to Sellas Life Sciences